{"id":7075,"date":"2026-05-12T09:17:03","date_gmt":"2026-05-12T12:17:03","guid":{"rendered":"http:\/\/nahoranoticias.com\/?p=7075"},"modified":"2026-05-12T09:17:05","modified_gmt":"2026-05-12T12:17:05","slug":"anvisa-libera-registro-de-remedios-para-tratar-psoriase-e-asma","status":"publish","type":"post","link":"https:\/\/nahoranoticias.com\/?p=7075","title":{"rendered":"Anvisa libera registro de rem\u00e9dios para tratar psor\u00edase e asma"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Yesintek tamb\u00e9m pode ser usado para Doen\u00e7a de Crohn<\/p>\n\n\n\n<figure class=\"wp-block-audio\"><audio controls src=\"https:\/\/tts-app.ebc.com.br\/media\/tts\/256593.mp3\"><\/audio><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) publicou hoje (11) o registro de dois medicamentos: um para tratamento de doen\u00e7as inflamat\u00f3rias cr\u00f4nicas e autoimunes, e outro para asma e rinossinusite cr\u00f4nica com p\u00f3lipos nasais grave.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1689062&amp;o=node\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1689062&amp;o=node\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O primeiro medicamento indicado \u00e9 Yesintek (Ustequinumabe), apresentado como solu\u00e7\u00e3o injet\u00e1vel pronta para administra\u00e7\u00e3o subcut\u00e2nea e para infus\u00e3o intravenosa.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O rem\u00e9dio \u00e9 indicado para tratar psor\u00edase, artrite psori\u00e1sica, doen\u00e7a de Crohn e colite ulcerativa. Segundo ao Anvisa, o produto foi avaliado pela via de desenvolvimento por comparabilidade, tendo sido comparado ao medicamento Stelara.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u201cYesintek \u00e9 biossimilar, ou seja, demonstra semelhan\u00e7a em termos de qualidade, seguran\u00e7a e efic\u00e1cia em rela\u00e7\u00e3o a um produto biol\u00f3gico de refer\u00eancia previamente registrado na Anvisa\u201d, disse a ag\u00eancia reguladora.<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">A ag\u00eancia disse ainda que o medicamento aprovado \u00e9 uma nova alternativa terap\u00eautica para pacientes adultos e crian\u00e7as acima de 6 anos com psor\u00edase em placa de grau moderado a grave.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cO tratamento \u00e9 direcionado especificamente para casos em que as terapias convencionais \u2014 como o uso de ciclosporina, metotrexato ou sess\u00f5es de fototerapia (PUVA) \u2014 n\u00e3o apresentaram resultados satisfat\u00f3rios, foram contraindicadas ou causaram intoler\u00e2ncia.\u201d&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ainda de acordo com a ag\u00eancia reguladora, no caso de pacientes adultos com artrite psori\u00e1sica ativa, o medicamento pode ser usado, de forma isolada ou em combina\u00e7\u00e3o com metotrexato, quando a resposta ao tratamento com drogas antirreum\u00e1ticas modificadoras da doen\u00e7a (DMARD) foi inadequada. O Yesintek \u00e9 indicado ainda para crian\u00e7as com mais de 6 anos com a doen\u00e7a ativa.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">No caso da doen\u00e7a de Crohn, o rem\u00e9dio \u00e9 indicado para pacientes adultos com quadro ativo de moderado a grave, que tiveram resposta inadequada ou perda de resposta a outros tratamentos, al\u00e9m de pessoas intolerantes \u00e0 terapia convencional ou ao anti-TNF-alfa (medicamentos imunobiol\u00f3gicos que bloqueiam uma prote\u00edna espec\u00edfica, reduzindo inflama\u00e7\u00f5es cr\u00f4nicas) ou que tenham contraindica\u00e7\u00f5es m\u00e9dicas para essas terapias.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Asma e rinossinusite cr\u00f4nica<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Tamb\u00e9m nesta segunda-feira, a Anvisa publicou o registro de um novo medicamento para tratar asma e rinossinusite cr\u00f4nica com p\u00f3lipos nasais grave, o Densurko\u00ae (depemoquimabe).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A medica\u00e7\u00e3o \u00e9 apresentada como solu\u00e7\u00e3o injet\u00e1vel 100 mg\/mL, em seringa preenchida ou caneta aplicadora, prontas para uso e indicada como tratamento complementar da asma em pacientes adultos e pedi\u00e1tricos com idade igual ou acima de 12 anos com inflama\u00e7\u00e3o do tipo 2 (al\u00e9rgica) caracterizada pelo excesso de eosin\u00f3filos (gl\u00f3bulos brancos envolvidos na inflama\u00e7\u00e3o das vias a\u00e9reas) no sangue.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Segundo o \u00f3rg\u00e3o, estudos cl\u00ednicos demonstraram redu\u00e7\u00e3o significativa na taxa de exacerba\u00e7\u00f5es clinicamente quando comparado ao placebo, ambos associados ao tratamento padr\u00e3o.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">No caso da rinossinusite cr\u00f4nica com p\u00f3lipos nasais, o medicamento \u00e9 indicado somente para pacientes adultos nos quais a terapia convencional (com corticosteroides sist\u00eamicos) e\/ou cirurgia n\u00e3o proporciona controle adequado do quadro.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nos dois casos, o tratamento indicado \u00e9 de uma dose a cada seis meses<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yesintek tamb\u00e9m pode ser usado para Doen\u00e7a de Crohn A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) publicou hoje (11) o&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7077,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"{\"document\":\"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\",\"updateId\":374653852}","footnotes":""},"categories":[80,11],"tags":[],"class_list":["post-7075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anvisa","category-saude"],"_links":{"self":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7075"}],"version-history":[{"count":1,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7075\/revisions"}],"predecessor-version":[{"id":7078,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7075\/revisions\/7078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/media\/7077"}],"wp:attachment":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}